DR. ELLIS D AVNER, MD
Medical Practice at Wisconsin Ave, Milwaukee, WI

License number
Wisconsin 47017
Category
Medical Practice
Type
Pediatric Nephrology
Address
Address
9000 W Wisconsin Ave, Milwaukee, WI 53226
Phone
(414) 337-7140
(414) 337-7145 (Fax)

Organization information

See more information about ELLIS D AVNER at bizstanding.com

Medical College Of Wisconsin - Ellis D Avner MD

9000 W Wisconsin Ave #3, Wauwatosa, WI 53226

Categories:
Physicians & Surgeons
Phone:
(414) 456-8296 (Phone)

Professional information

Ellis David Avner Photo 1

Ellis David Avner, Milwaukee WI

Specialties:
Pediatric Nephrologist
Address:
9000 W Wisconsin Ave, Milwaukee, WI 53226
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
Children's Hospital Boston - Fellowship - Pediatric Nephrology (Pediatrics)
Children's Hospital Boston - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Nephrology (Pediatrics)


Ellis D Avner Photo 2

Dr. Ellis D Avner - MD (Doctor of Medicine)

Hospitals:
9000 W Wisconsin Ave, Milwaukee 53226
Children's Hospital of Wisconsin
9000 West Wisconsin Ave, Milwaukee 53226
9000 W Wisconsin Ave, Milwaukee 53226
Children's Hospital of Wisconsin
9000 West Wisconsin Ave, Milwaukee 53226
Education:
Medical Schools
University Of Pennsylvania School Of Medicine
Graduated: 1975


Ellis David Avner Photo 3

Ellis David Avner, Milwaukee WI

Specialties:
Pediatrics, Pediatric Nephrology, Nephrology
Work:
Children's Hospital Wisconsin
9000 W Wisconsin Ave, Milwaukee, WI 53226
Education:
University of Pennsylvania(1975)


Ellis Avner Photo 4

Methods Of Modulating Cell Proliferation And Cyst Formation In Polycystic Kidney And Liver Diseases

US Patent:
2008016, Jul 10, 2008
Filed:
Sep 13, 2007
Appl. No.:
11/900722
Inventors:
William E. Sweeney - Waukesha WI, US
Ellis D. Avner - Milwaukee WI, US
Richard J. Roman - Brookfield WI, US
International Classification:
A61K 31/155, A61P 35/00, A61P 13/12
US Classification:
514637
Abstract:
The present invention provides a method for preferentially reducing the proliferation of cystic epithelial cells in the kidney or bile duct in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to preferentially reduce the proliferation of cystic epithelial cells over normal epithelial cells such as tubule epithelial cells in the kidney or bile duct. The present invention also provides a method for preventing or treating autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), ARPKD associated congenital hepatic fibrosis, ARPKD associated Caroli's disease, or cholangiocarcinoma in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to prevent or treat the disease.